FDA Inspection 1061515 — Gulf Coast Regional Blood Center
The FDA completed an inspection of Gulf Coast Regional Blood Center on May 25, 2018 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 25, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houston, TX (United States)